TCR Peptide Vaccination in Multiple Sclerosis: Boosting a Deficient Natural Regulatory Network that may Involve TCR-Specific CD4+CD25+ Treg Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5933|4|2|217-229

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.4, Iss.2, 2005-04, pp. : 217-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The TCR/CD3 Complex: Opening the Gate to Successful Vaccination

By  

Current Pharmaceutical Design, Vol. 15, Iss. 28, 2009-10 ,pp. : 3290-3300

Bentham Science Publishers

Access to resources Recommend Favorite

The Generation and Antigen-Specificity of CD4+CD25+ Regulatory T Cells

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-09 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite

MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 4, 2009-01 ,pp. : 344-352

Bentham Science Publishers

Access to resources Recommend Favorite

Antigen-Specific CD4+ Regulatory T Cells in the Intestine

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-09 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

CD4+CD25+ regulatory T cells: a therapeutic target for liver diseases

By Zheng Ming-Hua   Gu Dian-Na   Braddock Martin   Leishman Andrew J   Jin Chang   Wen Jin-Sheng   Gong Yue-Wen   Chen Yong-Ping  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 313-326

Informa Healthcare

Access to resources Recommend Favorite